Comparison of EUCAST and CLSI reference microdilution mics of eight antifungal compounds for candida auris and associated tentative epidemiological cutoff values

Antimicrobial Agents and Chemotherapy

Volumn 61, Issue 6, 2017, Pages

  Arendrup, M C ^a,b,c   Prakash, Anupam ^d   Meletiadis, Joseph ^e,f   Sharma, Cheshta ^d   Chowdhary, Anuradha ^d  

^a STATENS SERUM INSTITUT   (Denmark)

^b University of Copenhagen   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF DELHI   (India)

^e NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Amphotericin b; Antifungal susceptibility testing; Azoles; Candida auris; Echinocandins; Ecoff; In vitro; Mic

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; FLUCONAZOLE; ISAVUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE; ECHINOCANDIN; LIPOPEPTIDE; PYRROLE DERIVATIVE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA AURIS; CANDIDA PARAPSILOSIS; CANDIDIASIS; CONTROLLED STUDY; DERIVATIZATION; DILUTION; DRUG POTENCY; FUNGUS IDENTIFICATION; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PICHIA KUDRIAVZEVII; PRIORITY JOURNAL; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; AZOLES; CANDIDA; ECHINOCANDINS; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS;

EID: 85019693967     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00485-17     Document Type: Article

References (31)

1. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. 2009. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 53:41- 44. https://doi.org/10.1111/j.1348-0421.2008.00083.x.
2. Magobo RE, Corcoran C, Seetharam S, Govender NP. 2014. Candida auris-Associated candidemia, South Africa. Emerg Infect Dis 20: 1250-1251. https://doi.org/10.3201/eid2007.131765.
3. Lee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, Jang HC. 2011. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol 49:3139 -3142. https://doi.org/10.1128/JCM.00319-11.
4. Calvo B, Melo ASA, Perozo-Mena A, Hernandez M, Francisco EC, Hagen F, Meis JF, Colombo AL. 2016. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect 73:369 -374. https://doi.org/10.1016/j.jinf.2016.07.008.
5. Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP. 2017. Simultaneous emergence of multidrugresistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64:134 -140. https://doi.org/10.1093/cid/ciw691.
6. Public Health England. 2016. Candida auris identified in England. Public Health England, London, England. https://www.gov.uk/government/publications/candida-Auris-emergence-in-england/candida-Auris-identified-in-england.
7. Chowdhary A, Voss A, Meis JF. 2016. Multidrug-resistant Candida auris: "new kid on the block" in hospital-Associated infections? J Hosp Infect 94: 209-212. https://doi.org/10.1016/j.jhin.2016.08.004.
8. Ben-Ami R, Berman J, Novikov A, Bash E, Shachor-Meyouhas Y, Zakin S, Maor Y, Tarabia J, Schechner V, Adler A, Finn T. 23 February 2017. Multidrug-resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerg Infect Dis https://doi.org/10.3201/eid2302.161486.
9. Rudramurthy SM, Chakrabarti A, Paul RA, Sood P, Kaur H, Capoor MR, Kindo AJ, Marak RSK, Arora A, Sardana R, Das S, Chhina D, Patel A, Xess I, Tarai B, Singh P, Ghosh A. 20 February 2017. Candida auris candidaemia in Indian ICUs: Analysis of risk factors. J Antimicrob Chemother https://doi.org/10.1093/jac/dkx034.
10. European Centre for Disease Prevention and Control. 2016. Candida auris in healthcare settings, Europe, 19 December 2016. ECDC, Stockholm, Sweden.
11. Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, Jain S, Kathuria S, Randhawa HS, Hagen F, Meis JF. 2013. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis 19:1670 -1673. https://doi.org/10.3201/eid1910.130393.
12. Centers for Disease Control and Prevention. 2017. Candida auris. CDC, Atlanta, GA. https://www.cdc.gov/fungal/diseases/candidiasis/candida-Auris.html.
13. Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, Meis JF, Chowdhary A. 2015. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-Assisted laser desorption ionization-Time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol 53:1823-1830. https://doi.org/10.1128/JCM.00367-15.
14. Chowdhary A, Anil Kumar V, Sharma C, Prakash A, Agarwal K, Babu R, Dinesh KR, Karim S, Singh SK, Hagen F, Meis JF. 2014. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis 33:919 -926. https://doi.org/10.1007/s10096-013-2027-1.
15. Prakash A, Sharma C, Singh A, Kumar Singh P, Kumar A, Hagen F, Govender NP, Colombo AL, Meis JF, Chowdhary A. 2016. Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-Assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. Clin Microbiol Infect 22:277. e1-e9. https://doi.org/10.1016/j.cmi.2015.10.022.
16. Shin JH, Kim M-N, Jang SJ, Ju MY, Kim SH, Shin MG, Suh SP, Ryang DW. 2012. Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods. J Clin Microbiol 50:1852-1855. https://doi.org/10.1128/JCM.06440-11.
17. Arendrup MC, Garcia-Effron G, Lass-Flörl C, Lopez AG, Rodriguez-Tudela J-L, Cuenca-Estrella M, Perlin DS. 2010. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and IsoSensitest media. Antimicrob Agents Chemother 54: 426 - 439. https://doi.org/10.1128/AAC.01256-09.
18. Pfaller MA, Castanheira M, Messer SA, Rhomberg PR, Jones RN. 2014. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp. Diagn Microbiol Infect Dis 79:198 -204. https://doi.org/10.1016/j.diagmicrobio.2014.03.004.
19. Arendrup MC, Meletiadis J, Mouton JW, Guinea J, Cuenca-Estrella M, Lagrou K, Howard SJ. 2016. EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents. Clin Microbiol Infect 22:571. e1-e4. https://doi.org/10.1016/j.cmi.2016.01.01720.
20. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; third information supplement. CLSI document M27-A3. CLSI, Wayne, PA.
21. Turnidge J, Kahlmeter G, Kronvall G. 2006. Statistical characterisation of bacterial wild-Type MIC value distributions and the determination of epidemiological cut-off values. Clin Microbiol Infect 12:418-425. https://doi.org/10.1111/j.1469-0691.2006.01377.x.
22. Meletiadis J, Curfs-Breuker I, Meis JF, Mouton JW. 2017. In vitro antifungal susceptibility testing of Candida isolates with the EUCAST methodology, a new method for ECOFF determination. Antimicrob Agents Chemother 61:e02372-16. https://doi.org/10.1128/AAC.02372-16.
23. Emara M, Ahmad S, Khan Z, Joseph L, Al-Obaid I, Purohit P, Bafna R. 2015. Candida auris candidemia in Kuwait, 2014. Emerg Infect Dis 21: 1091-1092. https://doi.org/10.3201/eid2106.150270.
24. Ruiz Gaitán AC, Moret A, López Hontangas JL, Molina JM, Aleixandre López AI, Cabezas AH, Mollar Maseres J, Arcas RC, Gómez Ruiz MD, Chiveli MÁ Cantón E, Pemán J. 2017. Nosocomial fungemia by Candida auris: first four reported cases in continental Europe. Rev Iberoam Micol 34:23-27. https://doi.org/10.1016/j.riam.2016.11.002.
25. Chatterjee S, Alampalli SV, Nageshan RK, Chettiar ST, Joshi S, Tatu US. 2015. Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC Genomics 16:686. https://doi.org/10.1186/s12864-015-1863-z.
26. Jensen RH, Astvad KMT, Silva LV, Sanglard D, Jørgensen R, Nielsen KF, Mathiasen EG, Doroudian G, Perlin DS, Arendrup MC. 2015. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations. J Antimicrob Chemother 70:2551-2555. https://doi.org/10.1093/jac/dkv140.
27. Perlin DS, Shor E, Zhao Y. 2015. Update on antifungal drug resistance. Curr Clin Microbiol Rep 2:84 -95. https://doi.org/10.1007/s40588-015-0015-1.
28. Morio F, Loge C, Besse B, Hennequin C, Le Pape P. 2010. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azolesusceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn Microbiol Infect Dis 66:373-384. https://doi.org/10.1016/j.diagmicrobio.2009.11.006.
29. Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope WW, European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing. 2012. EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole. Clin Microbiol Infect 18: E248-E50. https://doi.org/10.1111/j.1469-0691.2012.03890.x.
30. Pfaller MA, Boyken LB, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ. 2008. Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: Results from a global Candida antifungal surveillance program. J Clin Microbiol 46: 3585-3590. https://doi.org/10.1128/JCM.01391-08.
31. Pfaller MA, Boyken LB, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ. 2011. Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: Application of epidemiological cutoff values to results from a global Candida antifungal surveillance program. J Clin Microbiol 49: 1274-1279. https://doi.org/10.1128/JCM.02437-10.